Researchers have developed a novel strategy to treat spinal muscular atrophy (SMA) by combining gene supplementation with CRISPR genome editing. The...
Spinal muscular atrophy is a severe neuromuscular disease caused by mutations in the SMN1 gene. While a few therapies have been approved for SMA, none...
